Hikma Pharmaceuticals PLC (HKMPF PINK) stock market data APIs
$23.4413
0.15(0.6%)
as of October 24, 2025
Try our APIs with
free plan!
Hikma Pharmaceuticals PLC Financial Data Overview
Price chart is built with
Anychart
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Prev. Close
23.4413
Open
23.5943
High
23.3465
Low
23.4413
52 wk Range
21.44-27.98
Market Cap
5 233 M
P/E Ratio
14
Shares Outstanding
221 M
Revenue
3 216 M
EPS
0.5345
Dividends (Yield)
0.0357
Beta
0.631
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hikma Pharmaceuticals PLC data using free add-ons & libraries
Get Hikma Pharmaceuticals PLC Fundamental Data
Hikma Pharmaceuticals PLC Fundamental data includes:
- Net Revenue: 3 216 M
- EBITDA: 764 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hikma Pharmaceuticals PLC News
New
FTSE 100 hits another high despite concerns over US government shutdown
The FTSE 100 hit another record high on Wednesday, despite concerns over the US shutdown, as pharmaceutical stocks powered higher, with AstraZeneca up 11% alone. The FTSE 100 index closed up 96.00 po...
Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
Roche Holding and AstraZeneca were among those companies posting increases as European pharma stocks tracked gains in the U.S. on Tuesday. Continue Reading View Comments
Hikma Pharmaceuticals PLC (LON:HIK) is favoured by institutional owners who hold 59% of the company
Key Insights Institutions' substantial holdings in Hikma Pharmaceuticals implies that they have significant influence over the company's share price 51% of the business is held by the top 10 sharehol...
If EPS Growth Is Important To You, Hikma Pharmaceuticals (LON:HIK) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
